Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Jim Cramer - Mad MoneySummit TherapeuticsSMMTDON'T BUYJan 31, 2025

Doesn't make money and is a risky spec.

$21.50

Stock price when the opinion was issued

$14.07

As of Jun 17, 2026. Market Open.

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY
The results of their cancer screening drug were poor

Move on.